Home
 /
Papers
 /
Bioinformatics
 /
Disentangled multimodal evolutionary representations for cross-virus predictive modeling of antigenic change
Preprint
Open access
V1
Top 1% · Validated by QED

Disentangled multimodal evolutionary representations for cross-virus predictive modeling of antigenic change

Zehong Zhang, Yuxi Lin, Siyun Zhong +3 more
February 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.02.12.705501
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Bioinformatics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Trained solely on pre-pandemic sequences, DERIVE anticipates variant emergence and immune escape weeks before clinical recognition across divergent viral families, demonstrating that generalizable pandemic threat assessment requires no real-time functional surveillance data.

QED claims analysis

Summary

DERIVE, a flow-based generative framework that learns disentangled multimodal representations of viral evolutionary history by integrating sequence homology with physicochemical and structural features, accurately predicts high-risk mutations and antigenic evolution using only pre-pandemic data for SARS-CoV-2 and generalizes robustly across structurally diverse viral families including influenza, HIV, rabies lyssavirus, and chikungunya virus with strong concordance to functional measurements.

See full analysis
Main Claim 1 –

DERIVE disentangles antigenicity from other evolutionary pressures

Supporting evidence

  • Disentangled latents align with expression, ACE2 binding, antibody escape
Main Claim 2 –

Pre-pandemic DERIVE predicts SARS-CoV-2 high-risk variants

Supporting evidence

  • DERIVE forecasting flags variants of concern weeks before WHO
Main Claim 3 –

DERIVE representations transfer across viruses, matching functional data

Abstract

Antigenic evolution drives immune escape and complicates early assessment of emerging pathogens, especially when genomic surveillance is sparse and functional measurements lag behind real-world spread. Early prediction and generalization to unknown viruses require faithful and information-rich representations of viral evolution, a need that is not fully addressed by existing protein language model–based approaches. Here we introduce DERIVE, a flow-based generative framework that learns a disentangled latent representation of multimodal evolutionary history by integrating sequence homology with physicochemical and structural features. Using only pre-pandemic SARS-CoV-2 sequences, DERIVE prioritizes high-risk mutations, reconstructs strain-level evolutionary trajectories, forecasts immune escape and prevalence trends, and produces mutation-level effect maps. The learned representation transfers robustly across viral families, with strong concordance to functional data for influenza virus, HIV, rabies lyssavirus and chikungunya virus. Together, these results position DERIVE as a generalizable and interpretable framework for anticipating antigenic evolution and supporting early, actionable assessment of future “Disease X” threats.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?